|
ARMCX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.61380020458068E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62581059726108E-12 |
| Stage1-vs-Stage2 |
7.398800E-01 |
| Stage1-vs-Stage3 |
3.372200E-01 |
| Stage1-vs-Stage4 |
2.403400E-01 |
| Stage2-vs-Stage3 |
3.725600E-01 |
| Stage2-vs-Stage4 |
2.638000E-01 |
| Stage3-vs-Stage4 |
6.984400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.335030E-03 |
| Normal-vs-Asian |
2.43705056135468E-12 |
| Caucasian-vs-AfricanAmerican |
8.691800E-02 |
| Caucasian-vs-Asian |
2.738000E-01 |
| AfricanAmerican-vs-Asian |
2.490600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.984600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
3.91750000000579E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.780200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.921800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.259000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.096400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.911000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.061800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.595000E-04 |
| Classical-VS-Follicular |
3.945800E-01 |
| Classical-VS-Other |
2.090800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
3.991800E-04 |
| Tall-VS-Other |
6.918100E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
4.168200E-01 |
| Follicular-VS-Normal |
3.35631522574431E-12 |
| Other-VS-Normal |
1.018290E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.195200E-04 |
|
|
